Adcock Ingram misses out on main ARV tender despite state’s localisation goal
SA pharmaceutical manufacturer overlooked as department of health awards half of R11bn antiretroviral tender to companies in India
A local pharmaceutical industry body is questioning why almost half of the main medicines in a three-year R11bn antiretroviral (ARV) tender will be bought from Indian companies while SA’s Adcock Ingram was overlooked...
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is reserved for DispatchLIVE subscribers.
Get access to ALL DispatchLIVE content from only R49.00 per month.
Already subscribed? Simply sign in below.
Already registered on HeraldLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.
Questions or problems? Email helpdesk@dispatchlive.co.za or call 0860 52 52 00.